Most recently, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor functions as a scavenger https://vannevary197svy8.blgwiki.com/user